• Postal address

    BT9 7BL

    United Kingdom

Organisation profile

Organisation profile

Our mission is to improve patient care through the development of:

- Biomarkers for prognosis, prediction and markers of response;
- Biologically determined targeted therapies.

The Centre for Cancer Research & Cell Biology (CCRCB) at Queen's University Belfast is a cross-Faculty, interdisciplinary research centre with over 300 clinical and basic researchers from across the world and is committed to the highest quality of research excellence. To achieve our mission we are pursuing the highest quality clinical and basic science research programmes. The hallmark of our research programme is a close, collaborative interaction between clinical and laboratory research experts that ultimately enhances the quality and scope of our integrated basic and clinical research programmes in cancer as well as other diseases.

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 10 - Reduced Inequalities
  • SDG 14 - Life Below Water
  • SDG 16 - Peace, Justice and Strong Institutions


Dive into the research topics where Patrick G Johnston Centre for Cancer Research is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation

    Richard Kennedy (Participant), Denis Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant) & Daniel Longley (Participant)

    Impact: Health Impact, Quality of Life Impact

  • Identifying Patients with Rare Forms of Erythrocytosis

    Mary McMullin (Participant), Terence Lappin (Participant) & Anne Hughes (Participant)

    Impact: Health Impact, Quality of Life Impact

  • Implementation of HPV-specific testing in addition to assessment of p16 expression in oropharyngeal squamous cell carcinoma

    Stephanie Craig (Participant), Lesley Anderson (Participant), Andrew Schache (Participant), Michael Moran (Participant), Laura Graham (Participant), Keith Currie (Participant), Keith Rooney (Participant), Max Robinson (Participant), Navdeep Upile (Participant), Rachel Brooker (Participant), Mina Mesri (Participant), Victoria Bingham (Participant), Kate Cuschieri (Participant), Stephen McQuaid (Participant), Terry Jones (Participant), Dennis McCance (Participant), Manuel Salto-Tellez (Participant), Simon McDade (Participant) & Jacqueline James (Participant)

    Impact: Health Impact, Quality of Life Impact